You searched for "cystic"
A pituitary tumour from 1927
The author shares a clinical case from Edinburgh Royal Infirmary’s archives. It is not often in the course of a clinical career that one gets the opportunity to review a patient who had been treated by a pioneer neurosurgeon some...The management of possibly progressive pterygium
1 February 2015
| Amit Patel, Peter McDonnell, M Quinlan
|
Cornea / External Eye Disease
A 43-year-old Sudanese male patient is referred by his GP with a fleshy lesion encroaching the nasal cornea for the last six months. History Make note of: risk factors, i.e. UV exposure and ocular irritation - history of living in...
Type 3 macular neovascularisation (MNV) due to age-related macular degeneration
3 October 2024
| Sofia Rokerya
|
Retina / Uvea / Vitreous
This paper systematically reviews and summarises the current knowledge on type 3 neovascularisation due to age-related macular degeneration which is defined as neovascularisation originating from the retinal deep capillary plexus that grows towards the outer retina often penetrating the level...
Pharmacopoeia of the Royal Infirmary of Edinburgh
4 February 2021
| Andrew King
|
Ophthalmology
The compact volume depicted in Figure 1 bears the simple title Pharmacopoeia. The book originally belonged to the author’s father, the late John King. A pharmacist by profession, John King maintained a keen interest in matters pertaining to pharmaceutical history....
Sensitive cilia – eyelashes in health and disease
5 October 2020
| Jonathan CP Roos, Rachna Murthy
|
Ophthalmology, Optometry, Cornea / External Eye Disease, Orbit, Oculoplastics
In health our eyelashes protect the eyes, but in disease they can disfigure, impair quality of life and threaten vision. In this review the authors discuss aspects of lashes that are relevant to all professionals working near the eyes and...
Cystoid macular oedema following cataract surgery
1 October 2019
| Ivan Yip
|
Cataract and Refractive
|
NSAIDs, cataract, cataract surgery, corticosteroids, cystoid macular oedema
This review covers the history, incidence, diagnosis, risk factors, pathophysiology and medical management of postoperative macular oedema (PCMO), with a particular emphasis on key contemporary studies and novel observations. The authors revisit the incidence of well-established risk factors including intraoperative...
Ozurdex in epiretinal membrane surgery
5 August 2020
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
This was a prospective multicentre pilot study, looking at the effect of Ozurdex on visual acuity (VA) and central retinal thickness (CRT) in patients undergoing surgery for epiretinal membrane (ERM). Twelve eyes of 12 patients were included in the study....
Topical nonsteroidal ant-inflammatory drugs (NSAIDs) in patients undergoing cataract surgery
4 February 2021
| Kurt Spiteri Cornish
|
Cataract and Refractive
|
Postoperative inflammation, cataract surgery, diclofenac, laser flare meter, nepafenac
Inflammation is a major risk factor for the development of cystoid macular oedema (CMO) after cataract surgery, leading to breakdown of the blood-retina barrier. There is a correlation between severity of CMO and level of postoperative inflammation. Laser flare meter...
Complications after cataract surgery in high myopes: a systematic review and meta-analysis
5 April 2022
| Mahmoud Ahmed
|
Cataract and Refractive
The authors review all the modern literature on complications after phacoemulsification in high myopes with axial lengths (AL) greater than 25.0mm. Twenty-eight studies reporting on 19,586 eyes were included. The corrected distance visual acuity (CDVA) improved from 0.96 ± 0.53...
Evaluation of fluocinolone acetonide in the management of BRC
1 June 2022
| Jonathan Chan
|
Retina / Uvea / Vitreous
This is a single-centre, retrospective, intervention study of 15 eyes of birdshot retinochoroiditis (BRC) patients who received Iluvein, with a mean follow-up period of 31 months. Five eyes had previously received dexamethasone intravitreal implant 0.7mg (Ozurdex). Fluorescein angiography (FA) showed...
Diclofenac versus Bromfenac after cataract surgery
1 April 2019
| Kurt Spiteri Cornish
|
Cataract and Refractive
|
Non-steroidal anti-inflammatory drugs, bromfenac, cataract surgery, diclofenac, intraocular inflammation
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used after cataract surgery to reduce inflammation and cystoid macular oedema (CMO). Diclofenac 0.1% is used three to five times daily for 28 days and Bromfenac 0.09% twice daily for 14 days postoperatively. The...
Correlation between anti-retinal antibodies and proliferative vitreoretinopathy (PVR)
1 October 2018
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Proliferative vitreoretinopathy, aqueous humor, autoantibodies, retinal detachment, vitreous
The pathological basis of PVR is not clearly understood and there are no effective medications targeting this condition. This cross-sectional study looked at the possible association of anti-retinal antibodies with patients with PVR and retinal detachment (RD). Aqueous and vitreous...